Literature DB >> 30224863

Electrophysiological Subtypes and Prognostic Factors of Childhood Guillain-Barré Syndrome.

Bahadır Konuşkan1, Çetin Okuyaz2, Bahar Taşdelen3, Semra Hiz Kurul4, Banu Anlar1.   

Abstract

INTRODUCTION: We assessed the clinical, epidemiologic, electrophysiological and prognostic characteristics of childhood Guillain-Barré Syndrome admitted to 13 pediatric neurology centers in Turkey.
METHOD: Using a standard data recording form age, sex, duration of symptoms, distribution of weakness at onset, cranial nerve involvement, cerebrospinal fluid findings, electrophysiological findings, duration of hospitalization, requirement of ventilation, treatment and clinical evaluation scale at onset, discharge and 1, 3, 6, and 12 months after discharge were recorded.
RESULTS: Among the 236 children with a median age of 6.8 years there was a male to female ratio of 1.3. Based on the electrophysiological features; 84 patients were classified as acute inflammatory demyelinating polyrediculoneuropathy (AIDP), 61 as acute motor axonal neuropathy (AMAN), 21 as acute motor-sensory axonal neuropathy (AMSAN). The incidence of cranial nerve involvement was 16%, and was related to lower clinical scores at discharge and 6 months after discharge. Clinical scale scores between axonal and demyelinating subgroups did not show statistically significant difference except for admission (p<0.05).
CONCLUSION: Electrophysiological subtypes are not important in prognosis in our series. However, duration of weakness, duration of hospitalization and ventilation requirement can affect prognosis negatively.

Entities:  

Keywords:  Guillain-Barré; Syndrome; childhood; electroneuromyography

Year:  2018        PMID: 30224863      PMCID: PMC6138236          DOI: 10.5152/npa.2017.16996

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  25 in total

1.  Attrition in longitudinal studies. How to deal with missing data.

Authors:  Jos Twisk; Wieke de Vente
Journal:  J Clin Epidemiol       Date:  2002-04       Impact factor: 6.437

2.  Guillain-Barré syndrome: incidence and mortality rates in US hospitals.

Authors:  Amer Alshekhlee; Zulfiqar Hussain; Badr Sultan; Bashar Katirji
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

Review 3.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

4.  The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre prospective study of 297 patients. The Italian Guillain-Barré Study Group.

Authors: 
Journal:  Brain       Date:  1996-12       Impact factor: 13.501

5.  Long-term outcome of Guillain-Barré syndrome in children.

Authors:  Joyce Roodbol; Marie-Claire Y de Wit; Femke K Aarsen; Coriene E Catsman-Berrevoets; Bart C Jacobs
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

6.  Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan.

Authors:  Kasumi Nagasawa; Satoshi Kuwabara; Sonoko Misawa; Katsunori Fujii; Yuzo Tanabe; Nobuhiro Yuki; Takamichi Hattori; Yoichi Kohno
Journal:  Muscle Nerve       Date:  2006-06       Impact factor: 3.217

Review 7.  Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  H S Patwa; V Chaudhry; H Katzberg; A D Rae-Grant; Y T So
Journal:  Neurology       Date:  2012-03-27       Impact factor: 9.910

8.  An acute axonal form of Guillain-Barré polyneuropathy.

Authors:  T E Feasby; J J Gilbert; W F Brown; C F Bolton; A F Hahn; W F Koopman; D W Zochodne
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

9.  Outcome of axonal and demyelinating forms of Guillain-Barré syndrome in children.

Authors:  Hasan Tekgul; Gul Serdaroglu; Sarenur Tutuncuoglu
Journal:  Pediatr Neurol       Date:  2003-04       Impact factor: 3.372

10.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  1 in total

1.  Impact of the COVID-19 Pandemic on the Frequency, Clinical Spectrum and Outcomes of Pediatric Guillain-Barré Syndrome in India: A Multicentric Ambispective Cohort Study.

Authors:  Divyani Garg; Rajinder K Dhamija; Aditya Choudhary; Ritu Shree; Sujit Kumar; Priyanka Samal; Abhishek Pathak; Pamidimukkala Vijaya; Yareeda Sireesha; Sruthi S Nair; Sanjay Sharma; Soaham Desai; Human P Sinha; Ayush Agarwal; Ashish Upadhyay; M V Padma Srivastava; Rohit Bhatia; Awadh K Pandit; Rajesh K Singh; Alisha Reyaz; P M Yogeesh; Manish Salunkhe; Vivek Lal; Manish Modi; Gagandeep Singh; Monika Singla; Samhita Panda; Maya Gopalakrishnan; Inder Puri; Sudhir Sharma; Bismay Kumar; Prashant K Kushwaha; Harshadkumar Chovatiya; Teresa Ferreira; Sanjeev K Bhoi; Manish Bhartiya; Subhash Kaul; Anuja Patil; Neeharika L Mathukumalli; Madhu Nagappa; P Praveen Sharma; Aneesh Basheer; Dileep Ramachandran; Neetha Balaram; Jospeh Sebastian; Venugopalan Y Vishnu
Journal:  Ann Indian Acad Neurol       Date:  2021-11-17       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.